The DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.
Monitoring tryptophan metabolism in chronic immune activation
Abstract
The essential amino acid tryptophan is a constituent of proteins and is also a substrate for two important biosynthetic pathways: the generation of neurotransmitter 5-hydroxytryptamine (serotonin) by tryptophan 5-hydroxylase, and the formation of kynurenine derivatives and nicotinamide adenine dinucleotides. The latter pathway is initiated by the enzymes tryptophan pyrrolase (tryptophan 2,3-dioxygenase, TDO) and indoleamine 2,3-dioxygenase (IDO). TDO is located in liver cells, whereas IDO is expressed in a variety of cells including monocyte-derived macrophages and dendritic cells and is preferentially induced by Th1-type cytokine interferon-gamma. Tryptophan depletion via IDO is part of the cytostatic and antiproliferative activity mediated by interferon-gamma in cells. In vivo tryptophan concentration can be measured by HPLC by monitoring its natural fluorescence (285 nm excitation and 365 nm emission wavelength). IDO activity is characterized best by the kynurenine to tryptophan ratio which correlates with concentrations of immune activation markers such as neopterin. Low serum/plasma tryptophan concentration is observed in infectious, autoimmune, and malignant diseases and disorders that involve cellular (Th1-type) immune activation as well as during pregnancy due to accelerated tryptophan conversion. Thus, in states of persistent immune activation, low tryptophan concentration may contribute to immunodeficiency. Decreased serum tryptophan can also effect serotonin biosyn…
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“The KYN/TRP ratio, particularly when comparing the concentration of IDO’s first product to the substrate, is a reliable indicator for tracking TRP degradation, which further implies enhanced IDO activity [48].”
Citations
Cites
Uyttenhove, C., Pilotte, L., Théate, I., Stroobant, V., Colau, D., Parmentier, N., Boon, T., & Van den Eynde, B. J. (2003) · Nature Medicine · doi:10.1038/nm934 · Cited by 2,305
Relationship between interferon‐γ, indoleamine 2,3‐dioxygenase, and tryptophan catabolism
Taylor, M. W., & Feng, G. (1991) · The FASEB Journal · doi:10.1096/fasebj.5.11.1907934 · Cited by 1,060
Capuron, L., Ravaud, A., Neveu, P. J., Miller, A. H., Maes, M., & Dantzer, R. (2002) · Molecular Psychiatry · doi:10.1038/sj.mp.4000995 · Cited by 473 · cited 3×
“Tryptophan degradation by IDO was found to be necessary for induction of tolerance to the fetus [51].”
BackgroundInfluential
Flagged first, then by citations
Research works printed but not linked: 71
- Yoshida, 1981, Induction of pulmonary indoleamine (2,3)-dioxygenase by interferon, Proc Natl Acad Sci U S A, 78, 129, 10.1073/pnas.78.1.129 · DOI
- Werner, 1987, Human macrophages degrade tryptophan upon induction by interferon gamma, Life Sci, 41, 273, 10.1016/0024-3205(87)90149-4 · DOI
- Hwu, 2000, Indoleamine 2,3-dioxygenase production by human dendritic cells results in the inhibition of T cell proliferation, J Immunol, 164, 3596, 10.4049/jimmunol.164.7.3596 · DOI
- Byrne, 1986, Induction of tryptophan degradation in vitro and in vivo: a gamma interferon stimulated activity, J Interferon Res, 6, 389, 10.1089/jir.1986.6.389 · DOI
- Werner-Felmayer, 1989, Characteristics of interferon induced tryptophan metabolism in human cells in vitro, Biochim Biophys Acta, 1012, 140, 10.1016/0167-4889(89)90087-6 · DOI
- Weiss, 1999, Modulation of neopterin formation and tryptophan degradation by Th1- and Th2-derived cytokines in human monocytic cells, Clin Exp Immunol, 116, 435, 10.1046/j.1365-2249.1999.00910.x · DOI
- Werner, 1988, Tryptophan degradation in patients infected by human immunodeficiency virus, Biol Chem Hoppe-Seyler, 369, 337, 10.1515/bchm3.1988.369.1.337 · DOI
- Fuchs, 1990, Decreased serum tryptophan in patients with HIV-1 infection correlates with increased serum neopterin and with neurologic/psychiatric symptoms, J Aquir Immune Defic Syndr, 3, 873
- Wirleitner, 2003, Immune activation and degradation of tryptophan in coronary heart disease, Eur J Clin Invest, 33, 550, 10.1046/j.1365-2362.2003.01186.x · DOI
- Denz, 1993, Weight loss in patients with hematological neoplasias is associated with immune system stimulation, Clin Investig, 71, 37, 10.1007/BF00210961 · DOI
- Heyes, 1992, Quinolinic acid and kynurenine pathway metabolism in inflammatory and non-inflammatory neurological disease, Brain, 115, 1249, 10.1093/brain/115.5.1249 · DOI
- Widner, 1997, Simultaneous measurement of serum tryptophan and kynurenine by HPLC, Clin Chem, 43, 2424, 10.1093/clinchem/43.12.2424 · DOI
- Wirleitner, 2003, Interferon-?-induced conversion of tryptophan: immunologic and neuropsychiatric aspects, Curr Med Chem, 10, 1581, 10.2174/0929867033457179 · DOI
- Pfefferkorn, 1984, Interferon gamma blocks the growth of Toxoplasma gondii in human fibroblasts by inducing the host cells to degrade tryptophan, Proc Natl Acad Sci U S A, 81, 908, 10.1073/pnas.81.3.908 · DOI
- de la Maza, 1988, Dependence of the in vitro antiproliferative activity of recombinant human gamma-interferon on the concentration of tryptophan in culture media, Cancer Res, 48, 346
- Ozaki, 1988, Induction of indoleamine 2,3-dioxygenase: a mechanism of the antitumor activity of interferon gamma, Proc Natl Acad Sci U S A, 85, 1242, 10.1073/pnas.85.4.1242 · DOI
- Munn, 1999, Inhibition of T cell proliferation by macrophage tryptophan catabolism, J Exp Med, 189, 1363, 10.1084/jem.189.9.1363 · DOI
- Munn, 2002, Potential regulatory function of human dendritic cells expressing indoleamine 2,3-dioxygenase, Science, 297, 1867, 10.1126/science.1073514 · DOI
- Grohmann, 2003, Tolerance, DCs and tryptophan: much ado about IDO, Trends Immunol, 24, 242, 10.1016/S1471-4906(03)00072-3 · DOI
- Terness, 2002, Inhibition of allogeneic T cell proliferation by indoleamine 2,3-dioxygenase-expressing dendritic cells: mediation of suppression by tryptophan metabolites, J Exp Med, 196, 447, 10.1084/jem.20020052 · DOI
- Frumento, 2002, Tryptophan-derived catabolites are responsible for inhibition of T and natural killer cell proliferation induced by indoleamine 2,3-dioxygenase, J Exp Med, 196, 459, 10.1084/jem.20020121 · DOI · Paper page
- Fuchs, 1989, Endogenous release of interferon-gamma and diminished response of peripheral blood mononuclear cells to antigenic stimulation, Immunol Lett, 23, 103, 10.1016/0165-2478(89)90120-X · DOI
- Laich, 2002, More rapid method for simultaneous measurement of tryptophan and kynurenine by HPLC, Clin Chem, 48, 579, 10.1093/clinchem/48.3.579 · DOI
- Steckel, 2005, Indoleamine 2,3-dioxygenase expression in monocytes of healthy nonpregnant women after induction with human choriongonadotropine, Scand J Immunol, 61, 213, 10.1111/j.0300-9475.2005.01538.x · DOI
- Widner, 2000, Interferon-gamma-induced tryptophan degradation: neuropsychiatry and immunological consequences, Curr Drug Metabol, 1, 193, 10.2174/1389200003339063 · DOI
- Fuchs, 1991, Increased endogenous interferon-gamma and neopterin correlate with increased degradation of tryptophan in human immunodeficiency virus type 1 infection, Immunol Lett, 28, 207, 10.1016/0165-2478(91)90005-U · DOI
- Huengsberg, 1998, Serum kynurenine-to-tryptophan ratio increases with progressive disease in HIV-infected patients, Clin Chem, 44, 858, 10.1093/clinchem/44.4.858 · DOI · Paper page
- Look, 2000, Parallel decrease in neurotoxin quinolinic acid and soluble tumor necrosis factor receptor p75 in serum during highly active antiretroviral therapy of HIV type 1 disease, AIDS Res Hum Retrovir, 16, 1215, 10.1089/08892220050116989 · DOI
- Gisslén, 1994, Tryptophan concentrations increase in cerebrospinal fluid and blood after zidovudine treatment in patients with HIV type 1 infection, AIDS Res Hum Retrovir, 10, 947, 10.1089/aid.1994.10.947 · DOI
- Zangerle, 2002, Effective antiretroviral therapy reduces degradation of tryptophan in patients with HIV-1 infection, Clin Immunol, 104, 242, 10.1006/clim.2002.5231 · DOI
- Pellegrin, 2005, Enhanced enzymatic degradation of tryptophan by indoleamine (2,3)-dioxygenase contributes to the tryptophan deficient state seen after major trauma, Shock, 23, 209
- Murr, 2001, Neopterin production and tryptophan degradation in humans infected by Streptococcus pyogenes, Med Microbiol Immunol, 189, 161, 10.1007/s430-001-8023-3 · DOI
- Fuchs, 1991, Kynurenine in cerebrospinal fluid of patients with Lyme neuroborreliosis, Immunol Infect Dis, 1, 271
- Wolf, 2004, Overexpression of indoleamine 2,3-dioxygenase (IDO) in human inflammatory bowel disease, Clin Immunol, 113, 47, 10.1016/j.clim.2004.05.004 · DOI
- Schroecksnadel, 2005, Tryptophan degradation in patients with gynecological cancer correlates with immune activation, Cancer Lett, 223, 323, 10.1016/j.canlet.2004.10.033 · DOI
- Iwagaki, 1995, Decreased serum tryptophan in patients with cancer cachexia correlates with increased serum neopterin, Immunol Invest, 24, 467, 10.3109/08820139509066843 · DOI
- Iwagaki, 1997, Cancer cachexia and depressive states: a neuro-endocrine-immunological disease?, Acta Med Okayama, 51, 233
- Giusti, 1996, Differential patterns of serum biomarkers of immune activation in human T-cell lymphotropic virus type I-associated myelopathy/tropical spastic pararesis and adult T-cell leukemia/lymphoma, Cancer Epidemiol Biomark Prev, 5, 699
- Huang, 2002, Tryptophan decrease in advanced colorectal cancer correlates with immune activation and impaired quality of life, Br J Cancer, 86, 1691, 10.1038/sj.bjc.6600336 · DOI
- Widner, 2000, Enhanced tryptophan degradation in systemic lupus erythematosus, Immunobiology, 201, 621, 10.1016/S0171-2985(00)80079-0 · DOI
- Forrest, 2003, Kynurenine and neopterin levels in patients with rheumatoid arthritis and osteoporosis during drug treatment, Adv Exp Med Biol, 527, 287, 10.1007/978-1-4615-0135-0_32 · DOI
- Schroecksnadel, 2003, Increased degradation of tryptophan in blood of patients with rheumatoid arthritis, J Rheumatol, 30, 1935
- Widner, 2000, Tryptophan degradation and immune activation in Alzheimer's disease, J Neural Trans, 107, 343, 10.1007/s007020050029 · DOI
- Leblhuber, 1998, Activated immune system in patients with Huntington's disease, Clin Chem Lab Med, 36, 747, 10.1515/CCLM.1998.132 · DOI
- Widner, 2002, Increased neopterin production and tryptophan degradation in advanced Parkinson's disease, J Neural Trans, 109, 181, 10.1007/s007020200014 · DOI
- Frick, 2004, Increasing production of homocysteine and neopterin and degradation of tryptophan with older age, Clin Biochem, 37, 684, 10.1016/j.clinbiochem.2004.02.007 · DOI
- Brown, 1986, Effects of interferon and interleukin-2 on tryptophan metabolism in humans, J Cell Biochem Suppl, 10C, 230
- Wirleitner, 2002, Monocyte-derived dendritic cells release neopterin, J Leukoc Biol, 72, 1148, 10.1189/jlb.72.6.1148 · DOI
- Schroecksnadel, 1996, Decreased plasma tryptophan in pregnancy, Obstet Gynecol, 88, 47, 10.1016/0029-7844(96)00084-1 · DOI
- Schroecksnadel, 2003, Longitudinal study of tryptophan degradation during and after pregnancy, Life Sci, 72, 785, 10.1016/S0024-3205(02)02304-4 · DOI
- Munn, 1998, Prevention of allogeneic fetal rejection by tryptophan catabolism, Science, 281, 1191, 10.1126/science.281.5380.1191 · DOI
- Fuchs, 1989, Neopterin as a predictive marker for disease progression in human immunodeficiency virus type 1 infection, Clin Chem, 35, 1746, 10.1093/clinchem/35.8.1746 · DOI
- Fahey, 1990, The prognostic value of cellular and serologic markers in infection with human immunodeficiency virus type 1, N Engl J Med, 322, 166, 10.1056/NEJM199001183220305 · DOI
- Fuchs, 1990, Increased serum neopterin in patients with HIV-1 infection is correlated with reduced in vitro interleukin-2 production, Clin Exp Immunol, 80, 44, 10.1111/j.1365-2249.1990.tb06439.x · DOI
- Fuchs, 1991, Immune activation and the anaemia associated with chronic inflammatory disorders, Eur J Haematol, 46, 65, 10.1111/j.1600-0609.1991.tb00524.x · DOI
- Weiss, 2004, Possible role of cytokine-induced tryptophan degradation in anaemia of inflammation, Eur J Haematol, 72, 130, 10.1046/j.0902-4441.2003.00197.x · DOI
- Owens, 1994, Role of serotonin in the pathophysiology of depression: focus on the serotonin transporter, Clin Chem, 40, 288, 10.1093/clinchem/40.2.288 · DOI
- Murr, 2000, Immune reaction links disease progression in cancer patients with depression, Med Hypotheses, 55, 137, 10.1054/mehy.1999.1043 · DOI
- Widner, 2002, Neopterin production tryptophan degradation and mental depression: what is the link?, Brain Behav Immun, 16, 590, 10.1016/S0889-1591(02)00006-5 · DOI
- Launay, 1988, Decreased whole blood 5-hydroxytryptamine (serotonin) in AIDS patients, J Acquir Immune Defic Syndr, 1, 324
- Maes, 1994, Increased neopterin and interferon-gamma secretion and lower availability of l-tryptophan in major depression: further evidence for an immune response, Psych Res, 54, 143, 10.1016/0165-1781(94)90003-5 · DOI · Paper page
- DeVane, 1998, Differential pharmacology of newer antidepressants, J Clin Psych, 59, 85
- Suarez, 2001, Outcome of patients with HIV-1-related cognitive impairment on highly active antiretroviral therapy, AIDS, 15, 195, 10.1097/00002030-200101260-00008 · DOI
- Gendelman, 1998, Suppression of inflammatory neurotoxins by highly active antiretroviral therapy in human immunodeficiency virus-associated dementia, J Infect Dis, 178, 1000, 10.1086/515693 · DOI
- Judd, 2000, Depressive symptoms reduced in individuals with HIV/AIDS treated with highly active antiretroviral therapy: a longitudinal study, Aust NZ J Psychiatry, 34, 1015, 10.1080/000486700278 · DOI
- Murray, 2003, Tryptophan depletion and HIV infection: a metabolic link to pathogenesis, Lancet Infect Dis, 3, 644, 10.1016/S1473-3099(03)00773-4 · DOI
- Cady, 1991, 1-Methyl-dl-tryptophan, beta-(3-benzofuranyl)-dl-alanine (the oxygen analog of tryptophan), and beta-[3-benzo(b)thienyl]-dl-alanine (the sulfur analog of tryptophan) are competitive inhibitors for indoleamine 2,3-dioxygenase, Arch Biochem Biophys, 291, 326, 10.1016/0003-9861(91)90142-6 · DOI
- Winkler, 2004, St. John's wort (Hypericum perforatum) counteracts cytokine-induced tryptophan catabolism in vitro, Biol Chem, 385, 1197, 10.1515/BC.2004.155 · DOI
- Schroecksnadel, 2005, Aspirin down-regulates tryptophan degradation in stimulated human peripheral blood mononuclear cells in vitro, Clin Exp Immunol, 140, 41, 10.1111/j.1365-2249.2005.02746.x · DOI
- Winkler, 2004, In vitro effects of two extracts and two pure alkaloid preparations of Uncaria tomentosa on peripheral blood mononuclear cells, Planta Med, 70, 205, 10.1055/s-2004-815536 · DOI
- Murr, 2005, Antioxidants may increase the probability of developing allergic diseases and asthma, Med Hypotheses, 64, 973, 10.1016/j.mehy.2004.11.011 · DOI
Cited by
Sorted by citations
Items 301–400 of 503
Ren, Y.-P., Tang, A., Zhou, Q.-X., & Xiang, Z.-Y. (2011) · Journal of clinical laboratory analysis (Print) · doi:10.1002/jcla.20467 · Cited by 17
“At least two enzymes, tryptophan 2,3-dioxygenase and indoleamine 2,3-dioxygenase (IDO), are involved in the KP (6,8,9).”
BackgroundSandvig, H. V., Aam, S., Alme, K., Lydersen, S., Ueland, P. M., Ulvik, A., Wethal, T., Saltvedt, I., & Knapskog, A. (2024) · Brain, behavior, and immunity · doi:10.1016/j.bbi.2024.02.030 · Cited by 16
“1) (Schr ¨ ocksnadel et al., 2006).”
Heylen, A., Vermeiren, Y., Kema, I. P., van Faassen, M. H. J. R., van der Ley, C., Dam, D. V., & Deyn, P. P. D. (2023) · Pharmaceuticals · doi:10.3390/ph16040615 · Cited by 16
The role of indoleamine 2,3‐dioxygenase in allergic disorders
Esmaeili, S., & Hajavi, J. (2022) · Molecular Biology Reports · doi:10.1007/s11033-021-07067-5 · Cited by 17
“A character of stimulated IDO1 was shown through the rise in the KYN/TRP ratio since KYN/TRP is associated with the density of the immune stimulation, such as autoimmune, infections, and neurodegenerative conditions [38, 39].”
BackgroundBoujelbène, N., Yahia, H. B., Babay, W., Gadria, S., Zemni, I., Azaiez, H., Dhouioui, S., Zidi, N., Mchiri, R., Mrad, K., et al. (2019) · HLA · doi:10.1111/tan.13536 · Cited by 18
“Recent studies proposed that tryptophan degradation by tumor cells may be proposed as a strategy for immune escape.(43) In addition, IDO was proposed as a promoter of metastasis in different gynecological cancers44–46 with a high activity in serum of VSCC patients.”
BackgroundCampochiaro, C., Lytton, S., Nihtyanova, S., Fuchs, D., Ong, V., & Denton, C. (2019) · Clinical Immunology · doi:10.1016/j.clim.2018.12.009 · Cited by 16
Self-citationKim, I.-S., Hwang, J., Hirano, M., Iwata, H., & Kim, E. (2016) · Comparative Biochemistry and Physiology Part C Toxicology & Pharmacology · doi:10.1016/j.cbpc.2016.03.011 · Cited by 18
Wang, H., Chen, Y., Zhao, A., Shen, Z., & Zhang, Y. (2026) · Frontiers in Pharmacology · doi:10.3389/fphar.2025.1709060 · Cited by 18
“…as those characterized by high levels of interferon-γ and TNF-α , which are commonly observed in MDD. Increased IDO activity could lead to heightened TRP degradation via the KYN pathway, subsequently reducing plasma TRP levels (Zhang et al., 2016; Chen et al., 2022; Schröcksnadel et al., 2006).”
Karthikeyan, B. S., Hyötyläinen, T., Ghaffarzadegan, T., Triplett, E. W., Orešič, M., & Ludvigsson, J. (2024) · Journal of Exposure Science & Environmental Epidemiology · doi:10.1038/s41370-024-00680-z · Cited by 25
“In addition, low circulating concentrations of tryptophan have been observed in infectious and autoimmune diseases and also in disorders that involve cellular (Th1-type) immune activation [68].”
BackgroundMetri, N., Butt, A. S., Murali, A., Steiner, G. Z., & Lim, C. K. (2023) · International Journal of Tryptophan Research · doi:10.1177/11786469231211184 · Cited by 18
Dai, M.-Z., Wang, Q., Kou, S.-S., Li, X., Jiang, Z., Sun, L., & Huang, X. (2022) · Journal of Pharmaceutical and Biomedical Analysis · doi:10.1016/j.jpba.2022.114979 · Cited by 15
Wang, X., Li, Y., Xie, M.-J., Deng, L., Zhang, M., & Xie, X.-J. (2020) · Biomedical chromotography · doi:10.1002/bmc.4792 · Cited by 15
Proschinger, S., Joisten, N., Rademacher, A., Schlagheck, M. L., Walzik, D., Metcalfe, A. J., Oberste, M., Warnke, C., Bloch, W., Schenk, A., et al. (2019) · BMC Neurology · doi:10.1186/s12883-019-1544-7 · Cited by 14
Tanaka, A., Kato, A., Suzuki, Y., Suzuki, M., Ohmori, H., Sumimoto, R., & Ohdan, H. (2014) · Therapeutic apheresis and dialysis · doi:10.1111/1744-9987.12071 · Cited by 15
“Therapeutic Apheresis and Dialysis 2014; 18(1):19–23 doi: 10.”
BackgroundVitamin B6 status and interferon‐γ‐mediated immune activation in primary hyperparathyroidism
Christensen, M., Pedersen, E., Nordbø, Y., Varhaug, J. E., Midttun, Ø., Ueland, P., Nygård, O., Mellgren, G., & Lien, E.-A. (2012) · Journal of Internal Medicine · doi:10.1111/j.1365-2796.2012.02570.x · Cited by 15
Girgin, G., Sahin, T. T., Fuchs, D., Kasuya, H., Yuksel, O., Tekin, E., & Baydar, T. (2009) · International Journal of Biological Markers · doi:10.5301/jbm.2009.2011 · Cited by 15
Self-citationMetabolomic pathways in food allergy
Lee, S., Park, Y. M., Yoo, H. J., & Hong, S. (2024) · Pediatric Allergy and Immunology · doi:10.1111/pai.14133 · Cited by 17
“60 Indole hinders the growth of both tumor cells and pathogens, as well as immune cells, by reducing the levels of tryptophan or by producing bioactive catab-olites.”
BackgroundInflammation, sex, blood pressure changes and hypertension in midlife: the Hordaland Health Study
Kringeland, E. A., Gerdts, E., Ulvik, A., Tell, G. S., Igland, J., Haugsgjerd, T. R., Ueland, P. M., & Midtbø, H. B. (2022) · Journal of Human Hypertension · doi:10.1038/s41371-022-00772-z · Cited by 20
“Further, there were no associations between KTR with systolic (β=−0.03) or diastolic (β= 0.02) BP in men (both p > 0.05) (Table 2, model 2).”
BackgroundInfluentialKarg, C., Parráková, L., Fuchs, D., Schennach, H., Kräutler, B., Moser, S., & Gostner, J. (2022) · Antioxidants · doi:10.3390/antiox11102056 · Cited by 14
Self-citationTryptophan-kynurenine profile in pediatric autoimmune hepatitis
Lytton, S. D., Osiecki, M., MałgorzataWoźniak, Cukrowská, B., Wierzbicka, A., Goliszek, M., Socha, P., Jańczyk, W., Dayanakli, D., Abendroth, D., et al. (2019) · Immunologic Research · doi:10.1007/s12026-019-9068-1 · Cited by 15
Self-citationBochniarz, M., Kocki, T., Dąbrowski, R., Szczubiał, M., Wawron, W., & Turski, W. (2018) · Reproduction in domestic animals = Zuchthygiene · doi:10.1111/rda.13299 · Cited by 14
Mergola, L., Orabona, C., Albini, E., Vasapollo, G., Scorrano, S., & Sole, R. D. (2018) · Journal of Separation Science · doi:10.1002/jssc.201800458 · Cited by 15
Potential role of indoleamine 2,3-dioxygenase in primary biliary cirrhosis.
Asghar, K., Brain, J., Palmer, J., Douglass, S. M., Naemi, F. M. A., O'boyle, G., Kirby, J., & Ali, S. (2017) · Oncology Letters · doi:10.3892/ol.2017.6834 · Cited by 14
“IDO activity is increased in autoimmune disorders and inflammation (43).”
Chen, Y.-H., Xie, Z., Xiao, C.-G., Zhang, M., Li, Z.-L., Xie, J.-T., Zhang, Y., Zhao, X.-C., Zeng, P.-F., Mo, L., et al. (2017) · OncoTarget · doi:10.18632/oncotarget.15705 · Cited by 14
Dąbrowski, R., Hagman, R., Tvarijonaviciute, A., Pastor, J., Kocki, T., & Turski, W. (2015) · Theriogenology · doi:10.1016/j.theriogenology.2015.01.009 · Cited by 14
“Thus, increased IDO activity could be the result of enhanced neutrophil and macrophage cytokine production [12,13].”
BackgroundResultInfluentialImmunomodulatory properties of cacao extracts – potential consequences for medical applications
Becker, K., Geisler, S., Ueberall, F., Fuchs, D., & Gostner, J. M. (2013) · Frontiers in Pharmacology · doi:10.3389/fphar.2013.00154 · Cited by 14
“Both, the flavanol content and the total antioxidant capacity increases in plasma after oral intake of cocoa or dark chocolate (Serafini et al., 2003; Spadafranca et al., 2010).”
BackgroundSelf-citationTemml, V., Kuehnl, S., Schuster, D., Schwaiger, S., Stuppner, H., & Fuchs, D. (2013) · FEBS Open Bio · doi:10.1016/j.fob.2013.08.008 · Cited by 13
Self-citationMangge, H., Schnedl, W., Schröcksnadel, S., Geisler, S., Murr, C., & Fuchs, D. (2013) · Pteridines · doi:10.1515/pterid-2013-0002 · Cited by 14
“Phe/ Tyr was calculated to estimate activity of enzyme phenylalanine hydroxylase (PAH) [ 11 , 18 , 19 ], and Kyn/Trp indicated the rate of tryptophan breakdown [ 5 ].”
BackgroundMethodSelf-citationImipramine reverses depressive-like parameters in pneumococcal meningitis survivor rats
Barichello, T., Milioli, G., Generoso, J. S., Cipriano, A. L., da Costa, C. S., Moreira, A. P., Vilela, M. C., Comim, C. M., Teixeira, A. L., & Quevedo, J. (2011) · Journal of Neural Transmission · doi:10.1007/s00702-011-0749-8 · Cited by 14
Picolinic Acid in Patients with Chronic Hepatitis C Infection: A Preliminary Report
Zuwała−Jagiełło, J., Pazgan−Simon, M., Simon, K. A., & Warwas, M. (2012) · Mediators of Inflammation · doi:10.1155/2012/762863 · Cited by 13
“In particular, the ratio of kynurenine to tryptophan (KYN/TRP) seems to be a sensitive indicator for interferon-γ-induced tryptophan degradation (reviewed in [18]).”
BackgroundKynurenine pathway can be a potential biomarker of fatigue in primary Sjögren's syndrome.
Park, Y., Lee, J., Koh, J., Kim, M.-J., Park, S.-H., & Kwok, S.-K. (2022) · Clinical and Experimental Rheumatology · doi:10.55563/clinexprheumatol/cp4st9 · Cited by 13
“Several studies have reported that IDO1 activity, represented by the ratio of kynurenine to tryptophan, and kynurenine metabolites are increased and correlated with fatigue in patients with systemic lupus erythematosus and rheumatoid arthritis (16, 17).”
BackgroundGhare, S. S., Singhal, R. A., Bryant, V. E., Gautam, S., Tirumala, C. C., Srisailam, P., Reyes-Vega, A., Ghooray, D. T., McClain, C. J., Hoffman, K. L., et al. (2022) · JAIDS Journal of Acquired Immune Deficiency Syndromes · doi:10.1097/qai.0000000000002866 · Cited by 16
Ghaffari‐Nasab, A., Badalzadeh, R., Mohaddes, G., Javani, G., Kalan, A. E., & Alipour, M. R. (2021) · Neurochemical Research · doi:10.1007/s11064-021-03440-9 · Cited by 16
Mutz, C. N., Schwentner, R., Kauer, M., Katschnig, A. M., Kromp, F., Aryee, D., Erhardt, S., Goiny, M., Alonso, J., Fuchs, D., et al. (2016) · FEBS Letters · doi:10.1002/1873-3468.12243 · Cited by 13
Self-citationYorucu, C., Lau, K., Mittar, S., Green, N. H., Raza, A., Rehman, I. U., & MacNeil, S. (2015) · Applied Spectroscopy Reviews · doi:10.1080/05704928.2015.1126840 · Cited by 16
Immunomodulatory effects in vitro of vitamin K antagonist acenocoumarol.
Schroecksnadel, S., Gostner, J., Jenny, M., Kurz, K., Schennach, H., Weiss, G., & Fuchs, D. (2013) · Thrombosis Research · doi:10.1016/j.thromres.2013.02.012 · Cited by 13
“, HIV infection, malignancy and autoimmune syndromes, increased neopterin concentrations are closely associated with higher kynurenine to tryptophan ratios (Kyn/Trp), and elevated neopterin levels and accelerated tryptophan breakdown reflect the course of disease and are predictive for an unfavourable outcome [7,15,16…”
BackgroundSelf-citationDurastanti, V., Lugaresi, A., Bramanti, P., Amato, M., Bellantonio, P., Luca, G. D., Picconi, O., Fantozzi, R., Locatelli, L., Soldà, A., et al. (2011) · Journal of Translational Medicine · doi:10.1186/1479-5876-9-42 · Cited by 13
“The kyn/trp ratio provides an estimate of IDO activity and correlates with markers of IFNg immune activation, like neopterin [8,12].”
BackgroundForton, D. M. (2006) · Gut · doi:10.1136/gut.2006.100081 · Cited by 18
The Interactions Between Kynurenine, Folate, Methionine and Pteridine Pathways in Obesity.
Engin, A., & Engin, A. (2017) · Advances in Experimental Medicine and Biology · doi:10.1007/978-3-319-48382-5_22 · Cited by 13
Dawson, B., & Favaloro, E. J. (2009) · Advances in Skin & Wound Care · doi:10.1097/01.asw.0000345280.20779.17 · Cited by 12
“2,3-dioxygenase is induced by cytokines, to facilitate the degradation of tryptophan via the kynurenine pathway.(12) If this is the cause of the decreased level of tryptophan, then increasing B group vitamins (B3 in particular) or providing a diet rich in omega-3 fatty acids may lessen the degradation and allow increa…”
BackgroundRong, Y., Tang, M., Liu, L., Ma, X.-G., Liu, M., Qu, L., Liao, X., Jiang, Q., Zhang, N., & Xu, X. (2024) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2024.118458 · Cited by 12
Indoleamine 2, 3-dioxygenase 1 inhibitory compounds from natural sources
Tan, Y., Liu, M., Li, M., Chen, Y., & Ren, M. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.1046818 · Cited by 14
“Interestingly, an imbalance in the Kyn/Trp ratio is often observed in inflammation-related disease, including infections and autoimmune disorders (Schröcksnadel et al., 2006; Huang et al., 2020).”
BackgroundXue, X., Miao, Y., & Wei, Z. (2022) · FEBS Letters · doi:10.1002/1873-3468.14528 · Cited by 14
Hoang, Q. T. M., Nguyễn, V. K., Oberacher, H., Fuchs, D., Hernandez-Vargas, E. A., Borucki, K., Waldburg, N., Wippermann, J., Schreiber, J., Bruder, D., et al. (2021) · Frontiers in Medicine · doi:10.3389/fmed.2021.676058 · Cited by 14
“We noticed an increase in serum IDO activity in our COPD cohort (Figure 4), which might be stimulated by IFN-γ or other pro-inflammatory cytokines (70) that are released in consequence of ongoing lung inflammation (71).”
BackgroundSelf-citationDhillon, A. K., Rupp, C., Bergquist, A. M., Voitl, R., Folseraas, T., Trøseid, M., Midttun, Ø., Ueland, P. M., Karlsen, T. H., Vesterhus, M. N., et al. (2021) · Scandinavian Journal of Gastroenterology · doi:10.1080/00365521.2021.1880627 · Cited by 13
“Speaking against that being the case, KT-ratio were similar in the cohorts and the well-known strong correlation between KT-ratio and neopterin, [27] was observed in all cohorts, despite neopterin, kynurenine and tryptophan having different biochemical characteristics including more stable concentrations during storag…”
ResultBaxter-Parker, G., Chu, A., Petocz, P., Samman, S., & Gieseg, S. (2019) · Pteridines · doi:10.1515/pteridines-2019-0003 · Cited by 12
“IDO activation is associated with increased inflammation and disease progression [13, 14].”
BackgroundVolgger, B., Windbichler, G., Zeimet, A., Graf, A., Bogner, G., Angleitner-Boubenizek, L., Rohde, M., Denison, U., Sliutz, G., Fuith, L., et al. (2016) · Annals of Oncology · doi:10.1093/annonc/mdw248 · Cited by 12
Self-citationCoelho, P., García-Léston, J., Costa, S., Costa, C., Silva, S., Fuchs, D., Geisler, S., Dall’Armi, V., Zoffoli, R., Bonassi, S., et al. (2014) · The Science of The Total Environment · doi:10.1016/j.scitotenv.2013.12.093 · Cited by 12
“In humans, an increased formation of neopterin and enhanced breakdown of tryptophan have been found in viral infections, malignant disorders and autoimmune diseases (Schroecksnadel et al., 2006).”
BackgroundInfluentialSelf-citationMechanisms of the effect of gut microbes on depression through the microbiota-gut-brain axis
Zhou, X., Wang, S., Wang, X., Chen, X., Zhou, P., Ma, K., & Zhang, P. (2025) · Frontiers in Nutrition · doi:10.3389/fnut.2025.1634548 · Cited by 14
Khoo, S. C., Zhang, N., Luang‐In, V., Goh, M. S., Sonne, C., & Ling, N. (2024) · Environmental Research · doi:10.1016/j.envres.2024.118441 · Cited by 13
Does smoking influence tryptophan metabolism in periodontal inflammation? A cross-sectional study.
Önder, C., Akdoğan, N., Kurgan, Ş., Balcı, N., Serdar, C. C., Serdar, M., & Günhan, M. (2023) · Journal of Periodontal Research · doi:10.1111/jre.13166 · Cited by 11
Aarsland, T. I. M., Instanes, J. T., Posserud, M.-B. R., Ulvik, A., Keßler, U., & Haavik, J. (2022) · Pharmaceuticals · doi:10.3390/ph15111439 · Cited by 13
“Inflammation Reduced levels of Trp and increased levels of kynurenines have been demonstrated in a range of clinical conditions involving immune activation, including infection, autoimmune disorders, cancer, neurodegenerative diseases and more (reviewed in [93,94]).”
BackgroundMechtcheriakov, S., von Gleissenthall, G., Geisler, S., Arnhard, K., Oberacher, H., Schurr, T., Kemmler, G., Unterberger, C., & Fuchs, D. (2022) · Alcoholism Clinical and Experimental Research · doi:10.1111/acer.14920 · Cited by 12
“Under normal conditions, the IDO- 1 degrades approximately 5% to 15% of TRP but it can be considerably activated by cytokines (Schröcksnadel et al., 2006).”
BackgroundSelf-citationSchenk, A., Esser, T., Knoop, A., Thevis, M., Herden, J., Heidenreich, A., Bloch, W., Joisten, N., & Zimmer, P. (2020) · Metabolites · doi:10.3390/metabo11010004 · Cited by 13
“KYN downstream metabolites and the KYN/TRP ratio are relevant biomarkers in diseases associated with chronic excesses or inflammation, including prostate cancer [51,52].”
BackgroundKink, P., Egger, E., Lanser, L., Klaunzner, M., Holzner, B., Willenbacher, W., Kasseroler, M. T., Fuchs, D., Weiss, G., & Kurz, K. (2020) · Journal of Clinical Medicine · doi:10.3390/jcm9103248 · Cited by 11
“Within T-helper cell type 1 (Th1), immune response to the pro-inflammatory cytokine interferon-γ (IFN-γ) induces the enzyme indoleamine 2,3-dioxygenase-1 (IDO) to degrade tryptophan to kynurenine (Kyn) [17,18].”
BackgroundSelf-citationYilmaz, N., Ustundağ, Y., Kıvrak, Ş., Kahvecioğlu, S., Celik, H., Kıvrak, İ., & Huysal, K. (2016) · Renal Failure · doi:10.1080/0886022x.2016.1209389 · Cited by 11
“Tryptophan and kynurenine levels provide information about IDO activity, which may inhibit activation and proliferation of T cells, natural killer cells, total lymphocytes, and monocytes.(7) In addition, IDO may play a critical role in the immunomodulatory enzymes that provide immunosuppression in several diseases, su…”
BackgroundBioactivites of two common polyphenolic compounds: Verbascoside and catechin
Si̇pahi̇, H., Gostner, J. M., Becker, K., Charehsaz, M., Kırmızıbekmez, H., Schennach, H., Aydın, A., & Fuchs, D. (2015) · Pharmaceutical Biology · doi:10.3109/13880209.2015.1072830 · Cited by 17
“…and tryptophan breakdown are well characterized as markers of immune activation in humans, which are closely associated with the course of clinical conditions like infections, malignant diseases, and autoimmune pathologies (Murr et al., 2002; Schroecksnadel et al., 2006; Taylor & Feng, 1991).”
BackgroundSelf-citationBlankfield, A. (2013) · International Journal of Tryptophan Research · doi:10.4137/ijtr.s11193 · Cited by 12
A Pilot Study on Neopterin Levels and Tryptophan Degradation in Zinc-Exposed Galvanization Workers
Saraç, E., Girgin, G., Palabıyık, Ş. S., Charehsaz, M., Aydın, A., Şahin, G., & Baydar, T. (2012) · Biological Trace Element Research · doi:10.1007/s12011-012-9569-4 · Cited by 17
“circumstances [35–39].”
Gietl, M., Burkert, F. R., Seiwald, S., Boehm, A., Hofer, S., Gostner, J. M., Piater, T., Geisler, S., Weiß, G., Löffler‐Ragg, J., et al. (2023) · International Journal of Tryptophan Research · doi:10.1177/11786469231154244 · Cited by 16
Self-citationZhou, Y., Li, T., Zhu, S., Gong, W., Qin, X., & Du, G. (2021) · Journal of Pharmacy and Pharmacology · doi:10.1093/jpp/rgab061 · Cited by 10
Hahn, D., Stokes, C. S., Kaiser, R., Meyer, M. R., Lammert, F., & Gruenhage, F. (2018) · European Journal of Clinical Investigation · doi:10.1111/eci.13024 · Cited by 10
Lin, H., Liu, Z.-Y., Pi, Z., Men, L.-H., Chen, W.-J., & Liu, Z.-Q. (2018) · Food & Function · doi:10.1039/c7fo01680h · Cited by 10
El‐Bakly, W. M., & Hasanin, A. H. (2014) · Korean Journal of Physiology and Pharmacology · doi:10.4196/kjpp.2014.18.3.233 · Cited by 11
“Thus, an increase in the ratio reflects greater enzyme activity, a decrease indicates lower activity [32].”
BackgroundSpecific Immunotherapy Normalizes Tryptophan Concentrations in Patients with Allergic Rhinitis
Kofler, H., Kurz, K., Grander, G., & Fuchs, D. (2012) · International Archives of Allergy and Immunology · doi:10.1159/000338937 · Cited by 10
Self-citationAmino Acids, Peptides, and Proteins
Hortin, G. L. (2012) · Elsevier eBooks · doi:10.1016/b978-1-4160-6164-9.00021-4 · Cited by 18
Superior normalization using total protein for western blot analysis of human adipocytes
Westerberg, L. J. S., Dedic, B., Näslund, E. B., Thorell, A., & Spalding, K. L. (2025) · PLoS ONE · doi:10.1371/journal.pone.0328136 · Cited by 10
Association between small intestine bacterial overgrowth and psychiatric disorders
Bogielski, B., Michalczyk, K., Głodek, P., Tempka, B., Gębski, W., & Stygar, D. M. (2024) · Frontiers in Endocrinology · doi:10.3389/fendo.2024.1438066 · Cited by 14
“The remaining portion of kynurenine metabolism takes place in the brain, liver, and GI tract, where is catalyzed by indoleamine 2,3-dioxygenase (IDO), whose expression can be induced by cytokines, especially those released during Th1-type immune responses, radicals, and interferons (47).”
BackgroundWu, C.-L., Huang, S., Liu, Z., Wang, Y., Zhu, Y., & Zang, Z. (2024) · Andrology · doi:10.1111/andr.13632 · Cited by 11
“38 The KYN pathway can diminish serum TRP concentration by activating IDO or TDO, 39 resulting in reduced TRP availability in the brain.”
Post-partum depression: From clinical understanding to preclinical assessments
Moreira, L. K. D. S., Moreira, C. V. L., Custódio, C. H. X., Dias, M. L. P., Rosa, D. A., Neto, M. L. F., Colombari, E., Costa, É. A., Fajemiroye, J. O., & Pedrino, G. R. (2023) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2023.1173635 · Cited by 10
“For instance, a report showed varying peripartum tryptophan with lower plasma concentration in the second and third trimesters as compared to the first trimester, and gradual postpartum restoration after 6 weeks (82).”
BackgroundWang, L., Yao, D., Urriola, P. E., Hanson, A. R., Saqui–Salces, M., Kerr, B. J., Shurson, G. C., & Chen, C. (2018) · The Journal of Nutritional Biochemistry · doi:10.1016/j.jnutbio.2018.04.009 · Cited by 11
Mapping the human proteome for non-redundant peptide islands
Capone, G., Marinis, A. D., Simone, S., Kusalik, A., & Kanduc, D. (2008) · Amino Acids · doi:10.1007/s00726-007-0563-7 · Cited by 9
“…et al. (2003) Tryptophan pyrrolase P14902 32 LPDFYNDWMFIA Tryptophan chronic immune activation in neurologic= psychiatric disorders Schrocksnadel et al. (2006) Psoriasis susceptibility 1 Q5ST21 49 MEPANHFWHAGD Psoriasis Szczerkowska-Dobosz (2005); Ozawa and Aiba…”
BackgroundMoheno, P. B. B., Pfleiderer, W., DiPasquale, A., Rheingold, A., & Fuchs, D. (2008) · International journal of pharmaceutics · doi:10.1016/j.ijpharm.2007.12.021 · Cited by 9
Self-citationSi̇pahi̇, H., Becker, K., Gostner, J. M., Charehsaz, M., Kırmızıbekmez, H., Schennach, H., Aydın, A., & Fuchs, D. (2013) · Fitoterapia · doi:10.1016/j.fitote.2013.10.012 · Cited by 8
Self-citationWang, H., Wu, J., Wei, H., Zhang, Y., Wang, Y., & Wang, D. W. (2024) · Inflammation · doi:10.1007/s10753-024-02100-8 · Cited by 8
“…concentration of the tryptophan and kynurenine, the kynurenine to tryptophan ratio (KTR) is a more useful index for assessing IDO1 activity and provides a better approach than directly measuring the metabolites, which is generally accepted as a surrogate indicator of IDO catabolic activity[3, 4].”
Kupjetz, M., Patt, N., Joisten, N., Ueland, P. M., McCann, A., Gonzenbach, R. R., Bansi, J., & Zimmer, P. (2023) · Multiple Sclerosis and Related Disorders · doi:10.1016/j.msard.2023.104592 · Cited by 9
C-Reactive Protein in Bipolar Disorder and Unipolar Depression
Zhang, X., Li, X., Tong, J., Li, N., & Zhang, F. (2022) · The Journal of Nervous and Mental Disease · doi:10.1097/nmd.0000000000001487 · Cited by 9
“Recent studies have suggested that inflammation may contribute to the development of BD (Maes, 2011; Müller and Schwarz, 2007; Schiepers et al., 2005; Schröcksnadel et al., 2006).”
BackgroundSamanic, C. M., Yue, Y., Coté, D. J., Stampfer, M. J., Wang, M., McCann, A., Midttun, Ø., Ueland, P. M., Smith‐Warner, S. A., & Egan, K. M. (2021) · Cancer Epidemiology · doi:10.1016/j.canep.2021.102075 · Cited by 8
Feng, Z., Hu, X.-Y., Qu, W.-Y., Zhu, X.-Q., Lu, J.-Y., Huang, Z.-D., Zhao, L., & Chen, P. (2021) · Evidence-Based Complementary and Alternative Medicine · doi:10.1155/2021/6655848 · Cited by 8
“Tryptophan can be involved in different pathways, including the kynurenine pathway, which has been reported to be regulated by altered immune responses [25].”
BackgroundReview of 10 years of research on breast cancer patients: Focus on indoleamine 2,3-dioxygenase
Asghar, K., Farooq, A., Zulfiqar, B., & Loya, A. (2021) · World Journal of Clinical Oncology · doi:10.5306/wjco.v12.i6.429 · Cited by 8
Hou, Y., Cao, C., Bao, W., Yang, S., Shi, H., Hao, D., Zhao, X.-J., & Wu, Y.-H. (2015) · Molecular Biosystems · doi:10.1039/c4mb00523f · Cited by 8
Cytokine-Induced Sickness Behavior and Depression
Chang, Q., Szegedi, S. S., O’Connor, J. C., Dantzer, R., & Kelley, K. W. (2008) · Springer eBooks · doi:10.1007/978-0-387-84851-8_9 · Cited by 5
Haverkamp, G. L. G., Loosman, W. L., Schouten, R. W., Franssen, C., Kema, I., van Diepen, M., Dekker, F., Siegert, C., & Honig, A. (2018) · General Hospital Psychiatry · doi:10.1016/j.genhosppsych.2017.10.003 · Cited by 8
Eleftheriadis, T., Pissas, G., Sounidaki, M., Antoniadi, G., Rountas, C. D., Liakopoulos, V., & Stefanidis, L. (2017) · Molecular and Cellular Biochemistry · doi:10.1007/s11010-016-2915-7 · Cited by 11
Engin, A., Karahalil, B., Karakaya, A., & Engin, A. (2010) · Pteridines · doi:10.1515/pteridines.2010.21.1.110 · Cited by 8
Gut microbiome dysregulation in noninfectious uveitis
Liu, M., Geng, J., Liu, T., & Liu, X. (2025) · Frontiers in Immunology · doi:10.3389/fimmu.2025.1614304 · Cited by 7
McHenry, L. C., Schürch, R., Gross, A. D., Johnson, L. E., Ohlinger, B. D., & Couvillon, M. J. (2025) · Journal of Experimental Biology · doi:10.1242/jeb.250124 · Cited by 9
Effects of Environmental Pollutants on Tryptophan Metabolism
Hu, H., Lu, X., Wu, M., Bai, Z., & Liu, X. (2025) · Toxics · doi:10.3390/toxics13040311 · Cited by 7
Duan, X.-Y., Wu, R., Li, J., Li, Z., Liu, Y.-Q., Chen, P., & Wang, B.-M. (2025) · Frontiers in Medicine · doi:10.3389/fmed.2025.1496023 · Cited by 7
Amino acid profiles, disease activity, and protein intake in adult patients with Crohn’s disease
Cioffi, I., Vincenzo, O. D., Imperatore, N., Fisco, M., Testa, A., Scialò, F., Castiglione, F., Ruoppolo, M., Pasanisi, F., & Santarpia, L. (2023) · Frontiers in Nutrition · doi:10.3389/fnut.2023.1245574 · Cited by 12
“Actually, low Trp levels have been reported in patients with various autoimmune disorders, including IBD (19, 52, 53).”
BackgroundLin, H., Liu, Z.-Y., Liu, Z.-Q., & Lin, Z. (2021) · Journal of Pharmaceutical and Biomedical Analysis · doi:10.1016/j.jpba.2021.114442 · Cited by 7
Alme, K. N., Askim, T., Aßmus, J., Mollnes, T. E., Naik, M., Næss, H., Saltvedt, I. T., Ueland, P. M., Ulvik, A., & Knapskog, A. (2021) · BMC Neurology · doi:10.1186/s12883-021-02343-0 · Cited by 9
“Neopterin and KTR are indirect measures of IFN-ɣ activity, which plays a central role in activating cellular immune response [19, 43].”
BackgroundPersonalized Medicine Using Neuroimmunological Biomarkers in Depressive Disorders
Chi, S., & Lee, M. (2021) · Journal of Personalized Medicine · doi:10.3390/jpm11020114 · Cited by 32
“This enzyme catalyzes the synthesis of kynurenine from tryptophan, a well-known precursor of serotonin, melatonin, and nicotinamide [30].”
BackgroundStudy of the plasmatic levels of tryptophan and kynurenine throughout pregnancy.
Alegre, E., López, A., Díaz-Lagares, Á., & González, Á. (2008) · Clinica chimica acta; international journal of clinical chemistry · doi:10.1016/j.cca.2008.03.011 · Cited by 7
Upadhyay, K. G., Desai, D., Ashavaid, T. F., & Dherai, A. J. (2025) · Scandinavian Journal of Gastroenterology · doi:10.1080/00365521.2025.2491784 · Cited by 7
“The K/T ratio was obtained by dividing the plasma concentration of Kyn by the obtained Trp concentration and multiplying the quotient by 1000 [19–23].”
Snider, S., Gagliardi, F., Domenico, P. D., Comai, S., Bertazzo, A., Nasini, S., Barzon, B., Ruban, A., Roncelli, F., & Mortini, P. (2025) · International Journal of Tryptophan Research · doi:10.1177/11786469241312475 · Cited by 6
Canales, G. D. L. T., Al‐Moraissi, E. A., Fatih, T., Razavian, A., Westman, J. S., Yanes, Y., Grigoriadis, A., Christidis, M., Christidis, N., & Barjandi, G. (2024) · Journal of Oral Rehabilitation · doi:10.1111/joor.13758 · Cited by 5
Gietl, M., Burkert, F. R., Hofer, S., Gostner, J. M., Sonnweber, T., Tancevski, I., Pizzini, A., Sahanic, S., Schroll, A., Brigo, N., et al. (2024) · Scientific Reports · doi:10.1038/s41598-024-57448-6 · Cited by 5
Yurt, E. F., Bicer, C. K., Serdar, M. A., Akan, S., & Erten, Ş. (2023) · Cytokine · doi:10.1016/j.cyto.2023.156247 · Cited by 6
Rezayei, E., Beheshtian, J., Shayeganfar, F., & Ramazani, A. (2022) · Journal of Molecular Modeling · doi:10.1007/s00894-022-05158-z · Cited by 9
“Trp is a nonpolar aromatic amino acid for the biosynthesis of proteins, which balances nitrogen and maintains the body weight and muscle mass in the human body [20, 21].”
Background
Metadata
- Authors
- Schröcksnadel, K., Wirleitner, B., Winkler, C., & Fuchs, D.
- Affiliations
- Innsbruck Medical University (AT)
- Corresponding author
- Fuchs, Dietmar
- Venue
- Clinica Chimica Acta
- Publisher
- Elsevier BV
- Published
- 2006-02
- Volume
- 364
- Issue
- 1-2
- Pages
- 82-90
- ISSN
- 0009-8981 (ISSN-L)
- OpenAlex
- W2042985653
- Cited by
- 551
- References
- 0
- Citations by year
- 2026: 7 · 2025: 25 · 2024: 19 · 2023: 24 · 2022: 32 · 2021: 47 · 2020: 31 · 2019: 21 · 2018: 27 · 2017: 34 · 2016: 26 · 2015: 32 · 2014: 24 · 2013: 38 · 2012: 36
- FWCI
- 0.80
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Clinica Chimica Acta (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Neuroscience › Biological Psychiatry › Tryptophan and brain disorders
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Biochemistry › Amino Acid Enzymes and Metabolism
- Life Sciences › Immunology and Microbiology › Immunology › Reproductive System and Pregnancy
- Keywords
- tryptophan metabolism, tryptophan depletion, indoleamine 2,3-dioxygenase, tryptophan 2,3-dioxygenase, kynurenine pathway, serotonin synthesis, interferon-gamma, chronic immune activation, Th1 response, neopterin, immunodeficiency, anemia, mood disorders, autoimmune disease, infectious diseases, pregnancy
- MeSH terms
- Autoimmune Diseases, Humans, Infections, Kynurenine, Neoplasms, Serotonin, Tryptophan, Tryptophan Hydroxylase, Tryptophan Oxygenase, Indoleamine-Pyrrole 2,3,-Dioxygenase
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review